|
EP0897986A3
(en)
*
|
1997-08-21 |
2000-07-05 |
Smithkline Beecham Corporation |
Aspartic proteinase 5 (ASP5)
|
|
US6203979B1
(en)
|
1998-01-16 |
2001-03-20 |
Incyte Pharmaceuticals, Inc. |
Human protease molecules
|
|
US7045333B1
(en)
|
1998-01-16 |
2006-05-16 |
Incyte Corporation |
Human protease molecules
|
|
US6432690B1
(en)
*
|
1998-01-16 |
2002-08-13 |
Incyte Genomics, Inc. |
Human aspartic proteases
|
|
US7160679B1
(en)
|
1998-05-21 |
2007-01-09 |
Diadexus, Inc. |
Method of diagnosing, monitoring, and staging lung cancer
|
|
EP1030911A1
(en)
*
|
1998-07-16 |
2000-08-30 |
Incyte Pharmaceuticals, Inc. |
Human aspartic proteases
|
|
EP1939297A1
(en)
|
1998-09-24 |
2008-07-02 |
Pharmacia & Upjohn Company LLC |
Alzheimer's disease secretase
|
|
US7115410B1
(en)
*
|
1999-02-10 |
2006-10-03 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
US7456007B1
(en)
|
1998-12-31 |
2008-11-25 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
CA2359785A1
(en)
|
1999-02-10 |
2000-08-17 |
John P. Anderson |
.beta.-secretase enzyme compositions and methods
|
|
US7514408B1
(en)
|
1999-12-02 |
2009-04-07 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
JP2001172200A
(ja)
*
|
1999-12-17 |
2001-06-26 |
Meneki Seibutsu Kenkyusho:Kk |
ヒトナプシンａに対する抗体およびこれを用いる医薬
|
|
CA2401749A1
(en)
|
2000-03-23 |
2001-09-27 |
Elan Pharmaceuticals, Inc. |
Compounds and methods to treat alzheimer's disease
|
|
WO2002000891A2
(en)
*
|
2000-06-26 |
2002-01-03 |
Bayer Aktiengesellschaft |
Human napsin-like aspartyl protease
|
|
US6846813B2
(en)
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
|
ATE314343T1
(de)
|
2000-06-30 |
2006-01-15 |
Elan Pharm Inc |
Verbindungen zur behandlung der alzheimerischen krankheit
|
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
|
EP1666452A2
(en)
|
2000-06-30 |
2006-06-07 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
|
EP1500663A1
(en)
*
|
2000-09-28 |
2005-01-26 |
Eli Lilly And Company |
Secreted proteins and their uses
|
|
US7806980B2
(en)
*
|
2000-12-23 |
2010-10-05 |
Elan Pharmaceuticals, Inc. |
Method for crystallizing human beta secretase in complex with an inhibitor
|
|
US7217556B1
(en)
|
2000-12-23 |
2007-05-15 |
Pfizer Inc |
Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease
|
|
US7601528B1
(en)
|
2000-12-23 |
2009-10-13 |
Elan Pharmaceuticals, Inc. |
Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease
|
|
US7524668B1
(en)
*
|
2001-05-10 |
2009-04-28 |
Elan Pharmaceuticals, Inc. |
Crystal of human beta secretase having monoclinic space group symmetry C2 and methods for crystallization thereof
|
|
US7384773B1
(en)
*
|
2001-05-10 |
2008-06-10 |
Pfizer Inc |
Crystal of HIV protease-cleaved human beta secretase and method for crystallization thereof
|
|
AU2002314914A1
(en)
|
2001-06-01 |
2002-12-16 |
Elan Pharmaceuticals, Inc. |
Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
|
|
EP1395251A2
(en)
|
2001-06-13 |
2004-03-10 |
Elan Pharmaceuticals, Inc. |
Aminediols as agents for the treatment of alzheimer's disease
|
|
JP2005500319A
(ja)
|
2001-06-27 |
2005-01-06 |
イーラン ファーマスーティカルズ、インコーポレイテッド |
アルツハイマー病の治療に有用なβ−ヒドロキシアミン誘導体
|
|
BR0211118A
(pt)
|
2001-07-10 |
2004-10-26 |
Elan Pharm Inc |
Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal
|
|
WO2003006453A1
(en)
|
2001-07-10 |
2003-01-23 |
Elan Pharmaceuticals, Inc. |
Aminediols for the treatment of alzheimer's disease
|
|
US7186539B1
(en)
|
2001-08-31 |
2007-03-06 |
Pharmacia & Upjohn Company |
Method for refolding enzymes
|
|
MXPA04003245A
(es)
|
2001-10-04 |
2004-08-11 |
Elan Pharm Inc |
Hidroxipropilaminas.
|
|
RS50504A
(sr)
|
2001-11-08 |
2007-04-10 |
Elan Pharmaceuticals Inc., |
Derivati n,n'-supstituisanog-1,3- diamino-2-hidroksipropana
|
|
CA2477243A1
(en)
|
2002-02-21 |
2003-09-04 |
Pharmacia & Upjohn Company |
Modified bace
|
|
US7262208B2
(en)
|
2002-04-30 |
2007-08-28 |
Elan Pharmaceuticals, Inc. |
Hydroxypropyl amides for the treatment of Alzheimer's disease
|
|
US7442537B1
(en)
|
2002-05-10 |
2008-10-28 |
Elan Pharmaceuticals, Inc. |
Crystals of unliganded beta secretase and/or beta secretase-like proteins and the use thereof
|
|
WO2004009797A2
(en)
*
|
2002-07-23 |
2004-01-29 |
Incyte Corporation |
Protein modification and maintenance molecules
|
|
CA2507484A1
(en)
|
2002-11-27 |
2004-06-17 |
Elan Pharmaceuticals, Inc. |
Substituted ureas and carbamates
|
|
TW200512195A
(en)
|
2003-04-21 |
2005-04-01 |
Elan Pharm Inc |
Benzamide 2-hydroxy-3-diaminoalkanes
|
|
JP4739192B2
(ja)
|
2003-05-02 |
2011-08-03 |
イーラン ファーマスーティカルズ、インコーポレイテッド |
Ｂａｃｅのグリコシル化変異体
|
|
WO2005044977A2
(en)
*
|
2003-06-25 |
2005-05-19 |
Diadexus, Inc. |
Compositions, splice variants and methods relating to lung specific genes and proteins
|
|
US20050239836A1
(en)
|
2004-03-09 |
2005-10-27 |
Varghese John |
Substituted hydroxyethylamine aspartyl protease inhibitors
|
|
WO2005095454A1
(en)
*
|
2004-03-25 |
2005-10-13 |
Diadexus, Inc. |
Lng105 antibody composition and methods of use, and use of lng105 to assess lung cancer risk
|
|
JP2008505930A
(ja)
|
2004-07-09 |
2008-02-28 |
エラン ファーマシューティカルズ，インコーポレイテッド |
オキシム誘導体置換ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬
|
|
WO2007047305A1
(en)
|
2005-10-12 |
2007-04-26 |
Elan Pharmaceuticals, Inc. |
Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
|
|
JP5450407B2
(ja)
|
2007-07-06 |
2014-03-26 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
置換アミノ−キナゾリノン、前記化合物を含む薬物、それらの使用及び製造方法
|